Company
Bio-Rad Laboratories, Inc.
Headquarters: Hercules, CA, United States
Founded: 1952
Employees: 7,900
CEO: Mr. Norman D. Schwartz
Market Cap
$9.30 Billion
USD as of Jan. 1, 2024
Bio-Rad Laboratories, Inc. Categories
United States Healthcare Medical DevicesUnited States Healthcare United States Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Bio-Rad Laboratories, Inc. has the following listings and related stock indices.
Stock: NYSE: BIO wb_incandescent
Stock: NYSE: BIO.B wb_incandescent
Stock: FSX: BUW wb_incandescent
Stock: XETR: BUWA wb_incandescent
Key People
Founder(s): David Schwartz Alice Schwartz
Norman Schwartz President & CEO Andy Last Chief Operating Officer Ilan Daskal CFO Michael Crowley E VP Global Commercial Operations Simon May President, Life Science Group Dara Wright President, Clinical Diagnostics Group
Financials
Revenue: US$2.545 Billion (Fiscal Year Ended December 31, 2020)
Operating income: US$410.957 Million (Fiscal Year Ended December 31, 2020)
Net income: US$3.806 Billion (Fiscal Year Ended December 31, 2020)
Total assets: US$12.972 Billion (Fiscal Year Ended December 31, 2020)
Total equity: US$9.879 Billion (Fiscal Year Ended December 31, 2020)